FDA plans changes to device approvals
WASHINGTON The Food and Drug Administration is laying out plans to update the 35-year-old system used to approve most medical devices, which has been subject to increasing criticism by public safety advocates.

FDA approves the Novartis quadrivalent meningococcal conjugate vaccine, Menveo , for use in children from 2 years of age
Novartis International AG / FDA approves the Novartis quadrivalent meningococcal conjugate vaccine, Menveo , for use in children from 2 years of age Processed and transmitted by Thomson Reuters. The issuer is solely responsible for the content